What is the contribution of molecular studies to the diagnosis of BCR-ABL-positive disease in adult acute leukemia?
- 28 February 1994
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 96 (2) , 133-138
- https://doi.org/10.1016/0002-9343(94)90133-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromosome-positive acute leukemiaBlood, 1991
- Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyBlood, 1991
- Detection of the Philadelphia chromosome in acute lymphoblastic leukemia by pulsed-field gel electrophoresisBlood, 1989
- Significance and correlations of molecular analysis results in patients with philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemiaThe American Journal of Medicine, 1988
- The Molecular Genetics of Philadelphia Chromosome–Positive LeukemiasNew England Journal of Medicine, 1988
- Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.Journal of Clinical Oncology, 1988
- A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemiaNature, 1987
- Unique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALLScience, 1987
- Rearrangement in the Breakpoint Cluster Region and the Clinical Course in Philadelphia-Negative Chronic Myelogenous LeukemiaAnnals of Internal Medicine, 1986
- Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemiaBlood, 1986